ursodeoxycholic acid has been researched along with Cardiovascular Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dohmen, K; Haruno, M; Tanaka, H | 1 |
Drozdova, LIu; Iakhontov, DA; Kutishenko, NP; Lerman, OV; Martsevish, SIu; Nevzorova, VA; Reznik, II; Shavkuta, GV | 1 |
Bagci, S; Demirci, H; Ozturk, K; Uygun, A | 1 |
Bueverova, EL; Drapkina, OM | 1 |
Abel, T; Fehér, J | 1 |
Balmer, ML; Dufour, JF | 1 |
3 review(s) available for ursodeoxycholic acid and Cardiovascular Diseases
Article | Year |
---|---|
[Ursodeoxycholic acid: A therapeutic niche in an internist's practice].
Topics: Biomedical Research; Cardiovascular Diseases; Cholagogues and Choleretics; Digestive System Diseases; Humans; Internal Medicine; Ursodeoxycholic Acid | 2015 |
[Non-alcoholic fatty liver disease and cardiovascular risk].
Topics: Antioxidants; Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Cytokines; Exercise; Fatty Acids, Nonesterified; Fatty Liver; Feeding Behavior; Humans; Insulin Resistance; Life Style; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Metabolic Syndrome; Obesity; Triglycerides; Ursodeoxycholic Acid | 2008 |
Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated.
Topics: Cardiovascular Diseases; Clofibric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Cirrhosis, Biliary; Risk Factors; Ursodeoxycholic Acid | 2008 |
3 other study(ies) available for ursodeoxycholic acid and Cardiovascular Diseases
Article | Year |
---|---|
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.
Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; PPAR alpha; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Uric Acid; Ursodeoxycholic Acid | 2013 |
[Ursodeoxycholic acid-enhanced efficiency and safety of statin therapy in patients with liver, gallbladder, and/or biliary tract diseases: the RACURS study].
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Diseases; Cardiovascular Diseases; Drug Synergism; Drug Therapy, Combination; Gallbladder Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Diseases; Middle Aged; Risk; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Effect of ursodeoxycholic acid on atherosclerosis.
Topics: Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Evidence-Based Medicine; Humans; Treatment Outcome; Turkey; Ursodeoxycholic Acid | 2015 |